vs
NVR, Inc.（NVR）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
NVR, Inc.的季度营收约是瑞思迈的1.9倍（$2.7B vs $1.4B），瑞思迈净利率更高（27.6% vs 13.4%，领先14.2%），瑞思迈同比增速更快（11.0% vs -4.7%），NVR, Inc.自由现金流更多（$436.0M vs $311.2M），过去两年瑞思迈的营收复合增速更高（9.0% vs 7.8%）
NVR, Inc.是总部位于美国弗吉尼亚州雷斯顿的知名住宅建造企业，同时运营抵押贷款银行及产权服务相关业务。公司业务主要布局美国东海岸，覆盖14个州及华盛顿特区，2021年有22%的营收来自华盛顿大都会区。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
NVR vs RMD — 直观对比
营收规模更大
NVR
是对方的1.9倍
$1.4B
营收增速更快
RMD
高出15.6%
-4.7%
净利率更高
RMD
高出14.2%
13.4%
自由现金流更多
NVR
多$124.8M
$311.2M
两年增速更快
RMD
近两年复合增速
7.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.7B | $1.4B |
| 净利润 | $363.8M | $392.6M |
| 毛利率 | — | 61.8% |
| 营业利润率 | — | 34.6% |
| 净利率 | 13.4% | 27.6% |
| 营收同比 | -4.7% | 11.0% |
| 净利润同比 | -20.5% | 13.9% |
| 每股收益（稀释后） | $120.85 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NVRRMD
| Q4 25 | $2.7B | $1.4B | ||
| Q3 25 | $2.6B | $1.3B | ||
| Q2 25 | $2.6B | $1.3B | ||
| Q1 25 | $2.4B | $1.3B | ||
| Q4 24 | $2.8B | $1.3B | ||
| Q3 24 | $2.7B | $1.2B | ||
| Q2 24 | $2.6B | $1.2B | ||
| Q1 24 | $2.3B | $1.2B |
净利润NVRRMD
| Q4 25 | $363.8M | $392.6M | ||
| Q3 25 | $342.7M | $348.5M | ||
| Q2 25 | $333.7M | $379.7M | ||
| Q1 25 | $299.6M | $365.0M | ||
| Q4 24 | $457.4M | $344.6M | ||
| Q3 24 | $429.3M | $311.4M | ||
| Q2 24 | $400.9M | $292.2M | ||
| Q1 24 | $394.3M | $300.5M |
毛利率NVRRMD
| Q4 25 | — | 61.8% | ||
| Q3 25 | — | 61.5% | ||
| Q2 25 | — | 60.8% | ||
| Q1 25 | — | 59.3% | ||
| Q4 24 | — | 58.6% | ||
| Q3 24 | — | 58.6% | ||
| Q2 24 | — | 58.5% | ||
| Q1 24 | — | 57.9% |
营业利润率NVRRMD
| Q4 25 | — | 34.6% | ||
| Q3 25 | — | 33.4% | ||
| Q2 25 | — | 33.7% | ||
| Q1 25 | — | 33.0% | ||
| Q4 24 | — | 32.5% | ||
| Q3 24 | — | 31.6% | ||
| Q2 24 | — | 31.2% | ||
| Q1 24 | — | 31.3% |
净利率NVRRMD
| Q4 25 | 13.4% | 27.6% | ||
| Q3 25 | 13.1% | 26.1% | ||
| Q2 25 | 12.8% | 28.2% | ||
| Q1 25 | 12.5% | 28.3% | ||
| Q4 24 | 16.1% | 26.9% | ||
| Q3 24 | 15.7% | 25.4% | ||
| Q2 24 | 15.3% | 23.9% | ||
| Q1 24 | 16.9% | 25.1% |
每股收益（稀释后）NVRRMD
| Q4 25 | $120.85 | $2.68 | ||
| Q3 25 | $112.33 | $2.37 | ||
| Q2 25 | $108.54 | $2.58 | ||
| Q1 25 | $94.83 | $2.48 | ||
| Q4 24 | $139.09 | $2.34 | ||
| Q3 24 | $130.50 | $2.11 | ||
| Q2 24 | $120.69 | $1.97 | ||
| Q1 24 | $116.41 | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.4B |
| 总债务越低越好 | — | $403.9M |
| 股东权益账面价值 | $3.9B | $6.3B |
| 总资产 | $5.9B | $8.5B |
| 负债/权益比越低杠杆越低 | — | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资NVRRMD
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $932.7M | ||
| Q4 24 | — | $521.9M | ||
| Q3 24 | — | $426.4M | ||
| Q2 24 | — | $238.4M | ||
| Q1 24 | — | $237.9M |
总债务NVRRMD
| Q4 25 | — | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | — | $662.9M | ||
| Q3 24 | — | $667.6M | ||
| Q2 24 | — | $697.3M | ||
| Q1 24 | — | $997.0M |
股东权益NVRRMD
| Q4 25 | $3.9B | $6.3B | ||
| Q3 25 | $4.0B | $6.1B | ||
| Q2 25 | $3.8B | $6.0B | ||
| Q1 25 | $4.0B | $5.5B | ||
| Q4 24 | $4.2B | $5.3B | ||
| Q3 24 | $4.3B | $5.2B | ||
| Q2 24 | $4.1B | $4.9B | ||
| Q1 24 | $4.3B | $4.6B |
总资产NVRRMD
| Q4 25 | $5.9B | $8.5B | ||
| Q3 25 | $6.0B | $8.3B | ||
| Q2 25 | $5.9B | $8.2B | ||
| Q1 25 | $6.2B | $7.6B | ||
| Q4 24 | $6.4B | $7.1B | ||
| Q3 24 | $6.5B | $7.2B | ||
| Q2 24 | $6.4B | $6.9B | ||
| Q1 24 | $6.5B | $6.8B |
负债/权益比NVRRMD
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $439.7M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $436.0M | $311.2M |
| 自由现金流率自由现金流/营收 | 16.1% | 21.9% |
| 资本支出强度资本支出/营收 | 0.1% | 2.0% |
| 现金转化率经营现金流/净利润 | 1.21× | 0.87× |
| 过去12个月自由现金流最近4个季度 | $1.1B | $1.8B |
8季度趋势，按日历期对齐
经营现金流NVRRMD
| Q4 25 | $439.7M | $339.7M | ||
| Q3 25 | $438.7M | $457.3M | ||
| Q2 25 | $35.1M | $538.8M | ||
| Q1 25 | $207.8M | $578.7M | ||
| Q4 24 | $637.0M | $308.6M | ||
| Q3 24 | $358.3M | $325.5M | ||
| Q2 24 | $232.7M | $440.1M | ||
| Q1 24 | $146.5M | $402.0M |
自由现金流NVRRMD
| Q4 25 | $436.0M | $311.2M | ||
| Q3 25 | $433.3M | $414.4M | ||
| Q2 25 | $26.8M | $508.2M | ||
| Q1 25 | $200.7M | $557.9M | ||
| Q4 24 | $631.5M | $288.0M | ||
| Q3 24 | $350.1M | $307.7M | ||
| Q2 24 | $226.3M | $415.2M | ||
| Q1 24 | $137.5M | $380.8M |
自由现金流率NVRRMD
| Q4 25 | 16.1% | 21.9% | ||
| Q3 25 | 16.6% | 31.0% | ||
| Q2 25 | 1.0% | 37.7% | ||
| Q1 25 | 8.4% | 43.2% | ||
| Q4 24 | 22.2% | 22.5% | ||
| Q3 24 | 12.8% | 25.1% | ||
| Q2 24 | 8.7% | 33.9% | ||
| Q1 24 | 5.9% | 31.8% |
资本支出强度NVRRMD
| Q4 25 | 0.1% | 2.0% | ||
| Q3 25 | 0.2% | 3.2% | ||
| Q2 25 | 0.3% | 2.3% | ||
| Q1 25 | 0.3% | 1.6% | ||
| Q4 24 | 0.2% | 1.6% | ||
| Q3 24 | 0.3% | 1.5% | ||
| Q2 24 | 0.2% | 2.0% | ||
| Q1 24 | 0.4% | 1.8% |
现金转化率NVRRMD
| Q4 25 | 1.21× | 0.87× | ||
| Q3 25 | 1.28× | 1.31× | ||
| Q2 25 | 0.11× | 1.42× | ||
| Q1 25 | 0.69× | 1.59× | ||
| Q4 24 | 1.39× | 0.90× | ||
| Q3 24 | 0.83× | 1.05× | ||
| Q2 24 | 0.58× | 1.51× | ||
| Q1 24 | 0.37× | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NVR
| Home Building Segment | $2.6B | 97% |
| Mortgage Banking Segment | $77.4M | 3% |
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
